Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 3:36 pm Sale | 2024-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | MFN Partners Management LP | 0 0.000% | -17,341![]() (Position Closed) | Filing History |
| 2025-02-12 1:25 pm Unchanged | 2024-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | American Endowment Foundation | 19,004 4.910% | 0 (Unchanged) | Filing History |
| 2025-02-12 09:28 am Sale | 2024-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 677 0.200% | -22,587![]() (-97.09%) | Filing History |
| 2024-12-06 4:05 pm Sale | 2024-11-30 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 0 0.000% | -51,126![]() (Position Closed) | Filing History |
| 2024-07-12 6:17 pm Sale | 2024-07-12 | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal Participations S.a r.l. | 16,594 4.300% | -3,257![]() (-16.41%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | TYNDALL CAPITAL PARTNERS L P | 23,490 6.700% | 6,113![]() (+35.18%) | Filing History |
| 2024-02-09 5:06 pm Unchanged | 2023-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal Participations S.a r.l. | 19,851 5.700% | 0 (Unchanged) | Filing History |
| 2024-02-09 08:50 am Sale | 2024-02-08 | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 23,264 6.660% | -1,171![]() (-4.79%) | Filing History |
| 2024-01-22 3:44 pm Unchanged | 2023-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 51,126 14.600% | 0 (Unchanged) | Filing History |
| 2023-12-05 4:00 pm Purchase | 2023-11-30 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 120,128 26.900% | 46,062![]() (+62.19%) | Filing History |
| 2023-09-05 4:05 pm Purchase | 2023-08-23 | 13G | CYCLERION THERAPEUTICS INC CYCN | TYNDALL CAPITAL PARTNERS L P | 17,377 5.050% | 17,377![]() (New Position) | Filing History |
| 2023-05-23 4:00 pm Unchanged | 2023-05-19 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 74,066 19.990% | 0 (Unchanged) | Filing History |
| 2023-05-12 08:39 am Purchase | 2023-05-11 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 74,066 19.990% | 43,926![]() (+145.74%) | Filing History |
| 2023-04-03 07:30 am Purchase | 2023-03-31 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 30,140 9.200% | 140![]() (+0.47%) | Filing History |
| 2023-02-09 09:59 am Purchase | 2023-02-09 | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 24,435 7.865% | 5,739![]() (+30.70%) | Filing History |
| 2023-01-13 4:30 pm Unchanged | 2022-11-01 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 51,126 16.500% | 0 (Unchanged) | Filing History |
| 2022-11-21 5:00 pm Purchase | 2022-11-20 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 30,000 9.200% | 4,310![]() (+16.78%) | Filing History |
| 2022-10-21 5:13 pm Unchanged | 2022-10-21 | 13D | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 51,126 16.500% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:41 pm Purchase | 2021-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 51,126 16.490% | 6,868![]() (+15.52%) | Filing History |
| 2022-02-11 06:35 am Purchase | 2021-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal Participations S.a r.l. | 19,851 6.400% | 6,868![]() (+52.90%) | Filing History |

